SCHEMBL11240294

SCHEMBL11240294

CNC(=O)CN(C)[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17630129 0.76 CTSK (0.43)
SCHEMBL13567026 0.74 MCL1 (0.40)
SCHEMBL425466 0.74
SCHEMBL9255945 0.73 LMNA (0.36)
SCHEMBL207501 0.72
Hydrochloric Acid SCHEMBL29494595 0.72
SCHEMBL1247149 0.71
SCHEMBL15068246 0.71 TSHR (0.47)
SCHEMBL17173842 0.70
SCHEMBL1246920 0.70 ALDH1A1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140309251-A1 SPIROTHIENOPYRAN-PIPERIDINE DERIVATIVES AS ORL-1 RECEPTOR ANTAGONISTS FOR THEIR USE IN THE TREATMENT OF ALCOHOL DEPENDENCE AND ABUSE ELI LILLY AND COMPANY (US) 2014-10-16 US claimed
EP-2787995-B1 SPIROTHIENOPYRAN-PIPERIDINE DERIVATIVES AS ORL-1 RECEPTOR ANTAGONISTS FOR THEIR USE IN THE TREATMENT OF ALCOHOL DEPENDENCE AND ABUSE LILLY CO ELI (US) 2016-08-17 EP disclosed
US-4316898-A AS ANTIBIOTICS BOEHRINGER INGELHEIM KG (DE) 1982-02-23 US disclosed